Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Lett ; 295: 99-114, 2018 Oct 01.
Article in English | MEDLINE | ID: mdl-29908848

ABSTRACT

Tributyltin chloride (TBT) is an obesogen associated with various metabolic and reproductive dysfunctions after in utero exposure. However, few studies have evaluated TBT's obesogenic effect on adult ovaries. In this study, we assessed whether TBT's obesogenic effects resulted in adult ovarian adipogenesis and other reproductive abnormalities. TBT was administered to adult female Wistar rats, and their reproductive tract morphophysiology was assessed. We further assessed the ovarian mRNA/protein expression of genes that regulate adipogenesis. Rats exposed to TBT displayed abnormal estrous cyclicity, ovarian sex hormone levels, ovarian follicular development and ovarian steroidogenic enzyme regulation. Rats exposed to TBT also demonstrated abnormal ovarian adipogenesis with increased cholesterol levels, lipid accumulation, and PPARγ, C/EBP-ß and Lipin-1 expression. A negative correlation between the ovarian PPARγ expression and aromatase expression was observed in the TBT rats. Furthermore, TBT exposure resulted in reproductive tract atrophy, inflammation, oxidative stress and fibrosis. Ovarian dysfunctions also co-occurred with the uterine irregularities. Abnormal ovarian adipogenic markers occurring after TBT exposure may be associated with uterine irregularities. A positive correlation between the ovarian cholesterol levels and uterine inflammation was observed in the TBT rats. These findings suggest that TBT leads to ovarian obesogenic effects directly by abnormal adipogenesis and/or indirectly through adult reproductive tract irregularities.


Subject(s)
Adipogenesis/drug effects , Adipose Tissue/drug effects , Adiposity/drug effects , Environmental Pollutants/toxicity , Obesity/chemically induced , Ovary/drug effects , Trialkyltin Compounds/toxicity , Adipogenesis/genetics , Adipose Tissue/metabolism , Adipose Tissue/pathology , Adipose Tissue/physiopathology , Adiposity/genetics , Animals , Atrophy , Cholesterol/metabolism , Cholesterol Side-Chain Cleavage Enzyme/genetics , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Estrous Cycle/blood , Estrous Cycle/drug effects , Female , Fibrosis , Gene Expression Regulation, Enzymologic , Gonadal Steroid Hormones/blood , Lipid Droplets/drug effects , Lipid Droplets/metabolism , Obesity/metabolism , Obesity/pathology , Obesity/physiopathology , Ovarian Follicle/drug effects , Ovarian Follicle/metabolism , Ovarian Follicle/pathology , Ovary/metabolism , Ovary/pathology , Ovary/physiopathology , Oxidative Stress/drug effects , Pelvic Inflammatory Disease/chemically induced , Pelvic Inflammatory Disease/metabolism , Pelvic Inflammatory Disease/pathology , Pelvic Inflammatory Disease/physiopathology , Phosphoproteins/genetics , Phosphoproteins/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...